United Guardian UG
NASDAQ UG
$7.17 +0.05 (+0.73%)
As of: Sep 9, 2026 · 11:43 AM EDT

United Guardian (UG) Cash from Investing Activities (2010 - 2026)

United Guardian's (UG) quarterly Cash from Investing Activities came in at $134889.0 in Q2 2026, down 34.62% year-over-year from $206316.0 in Q2 2025, and up 347.94% quarter-over-quarter from $30113.0 in Q1 2026.

Analysis

United Guardian (UG) Cash from Investing Activities (2010 - 2026) Analysis & Trends

United Guardian has disclosed Cash from Investing Activities across 17 years of filings, most recently posting $134889.0 for Q2 2026.

  • In Q2 2026, Cash from Investing Activities fell 34.62% year-over-year to $134889.0; the TTM figure through Jun 2026 stood at -$545341.0 (up 90.15% YoY), while the FY2025 annual figure was $175343.0, up 102.48% from the prior year.
  • Cash from Investing Activities came in at $134889.0 for Q2 2026 at United Guardian, up from $30113.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $4.8 million in Q2 2023 to a low of -$5.6 million in Q3 2024.
  • Average Cash from Investing Activities over 5 years is -$61772.8, with a median of $3683.0 recorded in 2023.
  • Year-over-year, Cash from Investing Activities plunged 144210.54% in 2024 and soared 2496.8% in 2025.
  • Over 5 years, Cash from Investing Activities stood at $1.1 million in 2022, then slumped by 100.05% to -$579.0 in 2023, then sank by 144210.54% to -$835558.0 in 2024, then surged by 107.15% to $59766.0 in 2025, then jumped by 125.7% to $134889.0 in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were $134889.0 in Q2 2026, $30113.0 in Q1 2026, and $59766.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Johnson & Johnson 647.54 Bn 626.78 Bn 17.26 Bn -1.11 Bn
2 AbbVie 441.45 Bn 434.88 Bn 12.70 Bn -1.20 Bn
3 Merck 364.78 Bn 357.64 Bn 12.21 Bn -5.60 Bn
4 Novartis Ag 267.01 Bn 259.32 Bn 11.24 Bn -3.11 Bn
5 Pfizer 158.95 Bn 147.25 Bn 10.94 Bn 2.11 Bn
6 Sanofi 52.54 Bn 45.16 Bn 10.79 Bn -424.26 Mn
7 Revolution Medicines 44.23 Bn 44.23 Bn - -1.66 Bn
8 Incyte 25.36 Bn 20.82 Bn 1.57 Bn -51.79 Mn
9 United Therapeutics 21.31 Bn 18.65 Bn 683.80 Mn 87.50 Mn
10 United Guardian 32.95 Mn 23.36 Mn 1.55 Mn 134,889.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 134,889.00
Mar 31, 2026 30,113.00
Dec 31, 2025 59,766.00
Sep 30, 2025 -770,109.00
Jun 30, 2025 206,316.00
Mar 31, 2025 679,370.00
Dec 31, 2024 -835,558.00
Sep 30, 2024 -5.58 Mn
Jun 30, 2024 7,945.00
Mar 31, 2024 -665,478.00
Dec 31, 2023 -579.00
Sep 30, 2023 -72,052.00
Jun 30, 2023 4.85 Mn
Mar 31, 2023 -46,088.00
Dec 31, 2022 1.13 Mn
Sep 30, 2022 -594,901.00
Jun 30, 2022 406,278.00
Mar 31, 2022 -47,128.00
Dec 31, 2021 1.16 Mn
Sep 30, 2021 -1.08 Mn